ESQ
Esquire Financial Holdings, Inc.
Next earnings Jul 22, 2026 · consensus $1.59 EPS, $42.0M rev
Last earnings +4.3% on 2026-04-23
$120.34
▲ +1.34%$120.34▲ +27.61%
over 1Y
L $92.31H $120.34
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.3%
1W+3.6%
1M+9.5%
3M+10.7%
YTD+19.2%
1Y+27.6%
Buy
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 7 analysts
Buy
Niche legal-industry bank compounding earnings ~16%/yr at 17.5% ROE — 19.7x P/E is fair, not cheap, for this quality.
Diluted EPS $5.87 · FY2025
The read
Quality fundamentals and an attractive price line up (~62% below fair value) — the rarer case where both the business and the entry look good.
Esquire is a specialty commercial bank built around the U.S. legal industry — a defensible niche that has translated into compounding fundamentals: net income has grown from $17.9M in FY2021 to $50.8M in FY2025 (a ~30% CAGR), with FY2025 alone up 16.4% YoY and diluted EPS up 14.2% to $5.87. Total assets jumped 25% to $2.37B while stockholders' equity grew 22.1% to $290M, and retained earnings climbed 29.3% — the balance sheet is being built with internally generated capital rather than dilution (shares up only 2.4%). A 17.5% ROE in commercial banking is top-decile, and operating cash flow of $59.8M (+41.8%) comfortably exceeds reported net income, supporting earnings quality.
Valuation at 19.7x trailing EPS is a premium to the typical regional bank multiple (~10-12x) but is reasonable for a bank growing earnings mid-teens with this return profile — a PEG of roughly 1.2-1.4x. Cash of $236M nearly doubled YoY, dividends grew 21%, and the liabilities/equity ratio of 7.17x is normal for a depository (not a leverage red flag). Capex stepped up 343% off a tiny base ($3.16M) and D&A is just $1.22M, signaling an asset-light, scalable model.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 10:24 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Is ESQ a buy? The one-page verdict, explained →
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $17.9M | $28.5M | $41.0M | $43.7M | $50.8M |
| Diluted EPS | $2.26 | $3.47 | $4.91 | $5.14 | $5.87 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value—
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF18.3
PEG (trailing)1.25
Earnings yield4.9%
FCF yield5.5%
Quality & risk
ROIC (est.)—
Free cash flow$56.7M
Total debt—
Net cash$236M
Capital returns
Buyback yield0.0%
Dividend yield (est.)0.6%
Shareholder yield0.6%
Shares Δ YoY+2.4%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRecent disclosure tone has been improving.
- 8-K Shareholder vote2026-06-24
Annual meeting vote results; routine other event disclosure
- 8-K Other event2026-06-09
Other event disclosure with exhibits; likely dividend or routine update
- 8-K Shareholder vote2026-05-28
Annual meeting shareholder vote results disclosed
- 10-Q Quarterly report2026-05-11
Q1 2026 results; continued growth on $2.37B asset base, 17.5% ROE
- 8-K Other event2026-04-30
2026 proxy: director slate, exec comp and auditor ratification
- DEF 14A Proxy statement2026-04-30
2026 proxy: director slate, exec comp and auditor ratification
- 8-K Earnings results2026-04-23
Q1 2026 earnings release and investor materials disclosed
- 8-K Officer / director change2026-04-02
Executive officer/director change announced with related exhibits
- 10-K Annual report2026-03-13
FY25 NI $50.8M (+16%), EPS $5.87, assets +25%; clean audit opinion
Recent filings
all on EDGAR ↗425Filing2026-06-24open ↗8-KPeriod ending 2026-06-232026-06-24open ↗425Filing2026-06-09open ↗8-KPeriod ending 2026-06-092026-06-09open ↗8-KPeriod ending 2026-05-282026-05-28open ↗10-QPeriod ending 2026-03-312026-05-11open ↗424B3Filing2026-05-07open ↗EFFECTFiling2026-05-06open ↗CORRESPFiling2026-05-04open ↗S-4/AFiling2026-05-04open ↗3Period ending 2026-04-302026-05-01open ↗8-KPeriod ending 2026-04-302026-04-30open ↗
Frequently asked
- Is Esquire Financial Holdings, Inc. (ESQ) a buy?
- ESQ currently carries a Buy rating with 4/5 conviction, derived from its latest SEC filings. Niche legal-industry bank compounding earnings ~16%/yr at 17.5% ROE — 19.7x P/E is fair, not cheap, for this quality.
- What is ESQ's fair value?
- A Modified-Graham model based on ESQ's SEC fundamentals estimates a fair value of about $194.38. It is an estimate from reported earnings, not a price target.
- Is ESQ overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, ESQ currently appears undervalued relative to its SEC-grounded earnings power.
- What is Esquire Financial Holdings, Inc.'s quality score?
- ESQ scores 77.19801360315614/100 (grade B+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001531031, latest 10-Q filed 2026-05-11) · EODHD · Proprietary analysis · as of 6/25/2026, 2:24:14 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.